Back |
home / stock / dbvt / dbvt message board
Subject | By | Source | When |
---|---|---|---|
* * $DBVT Video Chart 04-04-2019 * * | ClayTrader | investorshub | 04/04/2019 9:47:50 PM |
Massive overreaction yes, still time to buy it | BostonSportsNut | investorshub | 03/04/2019 4:08:16 PM |
Hope springs eternal......steady slow climb, re submission happening | BostonSportsNut | investorshub | 03/04/2019 4:06:50 PM |
Yes...the issues all surround manufacturing and QC issues. | retireat40 | investorshub | 12/21/2018 4:01:20 PM |
anyone hear the cc? Earlier they said the | jdlamont | investorshub | 12/21/2018 3:51:30 PM |
* * $DBVT Video Chart 12-20-18 * * | ClayTrader | investorshub | 12/20/2018 10:18:18 PM |
$DBVT 1.1M Block Buy X $4.14 around @ | ~MulaGreen~ | investorshub | 12/20/2018 7:32:39 PM |
Wow...getting crushed. Now at $4.60 from $14 yesterday. | retireat40 | investorshub | 12/20/2018 2:41:54 PM |
They submitted and now have withdrawn submittal. $5.18 | retireat40 | investorshub | 12/20/2018 2:06:12 PM |
DBVT~~5.25 now,,62%% down | ALERTS100%to10000%GAIN | investorshub | 12/20/2018 2:04:49 PM |
Ahha, and now, life returns. The curtain is | BostonSportsNut | investorshub | 02/19/2018 11:53:32 PM |
FAILED. Stock falls from 48 to 19, but fighting | BostonSportsNut | investorshub | 10/20/2017 9:33:03 PM |
There is a data reveal upcoming, and the | joezapp | investorshub | 10/10/2017 4:48:37 PM |
DBV Technologies S.A.'s PT raised by Leerink Swann | BostonSportsNut | investorshub | 08/25/2017 12:45:28 PM |
Annnd back we go to 46 | BostonSportsNut | investorshub | 08/23/2017 9:52:18 PM |
News, Short Squeeze, Breakout and More Instantly...
DBV Technologies S.A. Company Name:
DBVT Stock Symbol:
NASDAQ Market:
Châtillon, France, May 17, 2024 DBV Technologies Announces Plan to Implement ADS Ratio Change DBV Technologies (Euronext: DBV – ISIN: FR0010417...
Châtillon, France, May 17, 2024 DBV Technologies Announces Plan to Implement ADS Ratio Change DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT—CUSIP: 23306J101), a clinical-stage biopharmaceutical company focused on treatment o...
Châtillon, France, May 16, 2024 DBV Technologies Announces Results of its 2024 Combined General Meeting Shareholders approved all proposed resol...